Evidence map›Paper›PMID 41079496›Full record

ReviewCureus2025

A Narrative Review of Thromboprophylaxis in Obese Patients Undergoing Surgery: What Do You Need to Know?

Luis Carreto, Maria Garcia

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Luis CarretoAnesthesiology, Hospital Ángeles Tijuana, Tijuana, MEX.
Maria GarciaAnesthesiology, Hospital General de Tijuana, Tijuana, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgeries in obese patients have increased significantly, leading to a rise in perioperative complications such as embolic events. Preventing these complications in obese patients presents pharmacological challenges and involves optimization of guidelines and follow-up considerations, as well as the need for sufficient evidence to ensure safety with minimal risk. In this literature review, we address aspects of dosing with unfractionated and low-molecular-weight heparins, the role of factor Xa inhibitors, and the initiation and duration of thromboprophylaxis in obese patients undergoing surgery. We also review the current role of inferior vena cava filters as a preventive measure.

Indexed as

bariatricobese patientsurgerythromboembolic eventthromboprophylaxis

Identifiers

PMID41079496
PMCPMC12511900

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.